Terns Pharmaceuticals, Inc. Share Price
TERNTerns Pharmaceuticals, Inc. Stock Performance
Open $52.65 | Prev. Close $52.66 | Circuit Range N/A |
Day Range $52.58 - $52.65 | Year Range $1.94 - $53.17 | Volume 4,30,360 |
Average Traded $52.60 |
Terns Pharmaceuticals, Inc. Share Price Chart
About Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Terns Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Apr-26 | $52.65 | $52.60 | +0.00% |
09-Apr-26 | $52.65 | $52.60 | -0.11% |
08-Apr-26 | $52.61 | $52.66 | +0.04% |
07-Apr-26 | $52.73 | $52.64 | -0.26% |
06-Apr-26 | $52.77 | $52.77 | +0.09% |
02-Apr-26 | $52.77 | $52.73 | -0.09% |
01-Apr-26 | $52.83 | $52.77 | +0.06% |
FAQs on Terns Pharmaceuticals, Inc. Share Price
Can I buy Terns Pharmaceuticals, Inc. shares in India?
What is the share price of Terns Pharmaceuticals, Inc.?
What is the 5 year returns of Terns Pharmaceuticals, Inc.?
What are the high & low stock price of Terns Pharmaceuticals, Inc. today?
What is the 52-week high and low of Terns Pharmaceuticals, Inc. stock?